Approval · Notice of Compliance 9727 · 2008
ZOSTAVAX: Notice of Compliance 9727
Issued August 22, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9727
- Date
- August 22, 2008
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOSTAVAX | 02315939 | Cancelled Post Market |
Medicinal ingredients
- VARICELLA ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN) 19,400 PFU per VIAL